Ally Bridge Group (Ny) LLC Freeline Therapeutics Holdings PLC Transaction History

Ally Bridge Group (Ny) LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.04 - $8.9 $1.22 Million - $3.58 Million	-401,747 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.15 - $13.9 $56,878 - $97,008	-6,979 Reduced 1.71%	401,747 $3.27 Million
Q1 2021 May 17, 2021	SELL	$12.3 - $18.2 $200,170 - $296,186	-16,274 Reduced 3.83%	408,726 $5.03 Million
Q4 2020 Feb 16, 2021	BUY	$14.94 - $18.3 $6.35 Million - $7.78 Million	425,000 New	425,000 $7.76 Million

30.1K

Ticker FRLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,972,300
Description
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.